NCT06774807View on ClinicalTrials.gov

Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 7, 2024

Conditions
Healthy
Interventions
OTHER

Saline infusion

Saline/NaCl (9mg/ml) intravenous infusion

OTHER

Saline injection

Saline/NaCl (9mg/ml) subcutaneous injection

OTHER

1nmol antagonist infusion

GLP-2 (1-33)/GLP-2(3-33) 1 nmol/kg/min

OTHER

4 nmol antagonist infusion

GLP-2 (1-33)/GLP-2 (3-33) 4 nmol/kg/min

OTHER

Agonist injection

GLP-2(1-33) subcutaneous injection

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

University of Copenhagen

OTHER

NCT06774807 - Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33) | Biotech Hunter | Biotech Hunter